Tags

Type your tag names separated by a space and hit enter

Gamma-glutamylcysteine synthetase and tryparedoxin 1 exert high control on the antioxidant system in Trypanosoma cruzi contributing to drug resistance and infectivity.
Redox Biol. 2019 09; 26:101231.RB

Abstract

Trypanothione (T(SH)2) is the main antioxidant metabolite for peroxide reduction in Trypanosoma cruzi; therefore, its metabolism has attracted attention for therapeutic intervention against Chagas disease. To validate drug targets within the T(SH)2 metabolism, the strategies and methods of Metabolic Control Analysis and kinetic modeling of the metabolic pathway were used here, to identify the steps that mainly control the pathway fluxes and which could be appropriate sites for therapeutic intervention. For that purpose, gamma-glutamylcysteine synthetase (γECS), trypanothione synthetase (TryS), trypanothione reductase (TryR) and the tryparedoxin cytosolic isoform 1 (TXN1) were separately overexpressed to different levels in T. cruzi epimastigotes and their degrees of control on the pathway flux as well as their effect on drug resistance and infectivity determined. Both experimental in vivo as well as in silico analyses indicated that γECS and TryS control T(SH)2 synthesis by 60-74% and 15-31%, respectively. γECS overexpression prompted up to a 3.5-fold increase in T(SH)2 concentration, whereas TryS overexpression did not render an increase in T(SH)2 levels as a consequence of high T(SH)2 degradation. The peroxide reduction flux was controlled for 64-73% by TXN1, 17-20% by TXNPx and 11-16% by TryR. TXN1 and TryR overexpression increased H2O2 resistance, whereas TXN1 overexpression increased resistance to the benznidazole plus buthionine sulfoximine combination. γECS overexpression led to an increase in infectivity capacity whereas that of TXN increased trypomastigote bursting. The present data suggested that inhibition of high controlling enzymes such as γECS and TXN1 in the T(SH)2 antioxidant pathway may compromise the parasite's viability and infectivity.

Authors+Show Affiliations

Departamento de Bioquímica, Instituto Nacional de Cardiología Ignacio Chávez, Ciudad de México, 14080, Mexico.Departamento de Bioquímica, Instituto Nacional de Cardiología Ignacio Chávez, Ciudad de México, 14080, Mexico.Departamento de Bioquímica, Instituto Nacional de Cardiología Ignacio Chávez, Ciudad de México, 14080, Mexico.Departamento de Biomedicina Molecular, Centro de Investigación y de Estudios Avanzados del IPN, Ciudad de México, 07360, Mexico.Departamento de Biomedicina Molecular, Centro de Investigación y de Estudios Avanzados del IPN, Ciudad de México, 07360, Mexico.Departamento de Bioquímica, Instituto Nacional de Cardiología Ignacio Chávez, Ciudad de México, 14080, Mexico.Departamento de Bioquímica, Instituto Nacional de Cardiología Ignacio Chávez, Ciudad de México, 14080, Mexico.Centre for Immunity, Infection and Evolution (CIIE) and Centre for Translational and Chemical Biology (CTCB), School of Biological Sciences, The University of Edinburgh, Edinburgh, Scotland, United Kingdom.Departamento de Bioquímica, Instituto Nacional de Cardiología Ignacio Chávez, Ciudad de México, 14080, Mexico.Departamento de Bioquímica, Instituto Nacional de Cardiología Ignacio Chávez, Ciudad de México, 14080, Mexico. Electronic address: emma_saavedra2002@yahoo.com.

Pub Type(s)

Journal Article
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

31203195

Citation

González-Chávez, Zabdi, et al. "Gamma-glutamylcysteine Synthetase and Tryparedoxin 1 Exert High Control On the Antioxidant System in Trypanosoma Cruzi Contributing to Drug Resistance and Infectivity." Redox Biology, vol. 26, 2019, p. 101231.
González-Chávez Z, Vázquez C, Mejia-Tlachi M, et al. Gamma-glutamylcysteine synthetase and tryparedoxin 1 exert high control on the antioxidant system in Trypanosoma cruzi contributing to drug resistance and infectivity. Redox Biol. 2019;26:101231.
González-Chávez, Z., Vázquez, C., Mejia-Tlachi, M., Márquez-Dueñas, C., Manning-Cela, R., Encalada, R., Rodríguez-Enríquez, S., Michels, P. A. M., Moreno-Sánchez, R., & Saavedra, E. (2019). Gamma-glutamylcysteine synthetase and tryparedoxin 1 exert high control on the antioxidant system in Trypanosoma cruzi contributing to drug resistance and infectivity. Redox Biology, 26, 101231. https://doi.org/10.1016/j.redox.2019.101231
González-Chávez Z, et al. Gamma-glutamylcysteine Synthetase and Tryparedoxin 1 Exert High Control On the Antioxidant System in Trypanosoma Cruzi Contributing to Drug Resistance and Infectivity. Redox Biol. 2019;26:101231. PubMed PMID: 31203195.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Gamma-glutamylcysteine synthetase and tryparedoxin 1 exert high control on the antioxidant system in Trypanosoma cruzi contributing to drug resistance and infectivity. AU - González-Chávez,Zabdi, AU - Vázquez,Citlali, AU - Mejia-Tlachi,Marlen, AU - Márquez-Dueñas,Claudia, AU - Manning-Cela,Rebeca, AU - Encalada,Rusely, AU - Rodríguez-Enríquez,Sara, AU - Michels,Paul A M, AU - Moreno-Sánchez,Rafael, AU - Saavedra,Emma, Y1 - 2019/05/28/ PY - 2018/12/10/received PY - 2019/01/31/revised PY - 2019/05/27/accepted PY - 2019/6/17/pubmed PY - 2020/2/29/medline PY - 2019/6/17/entrez KW - Benznidazol KW - Flux control coefficient KW - Gamma-glutamylcysteine synthetase KW - Trypanothione KW - Trypanothione reductase KW - Trypanothione synthetase KW - Tryparedoxin SP - 101231 EP - 101231 JF - Redox biology JO - Redox Biol VL - 26 N2 - Trypanothione (T(SH)2) is the main antioxidant metabolite for peroxide reduction in Trypanosoma cruzi; therefore, its metabolism has attracted attention for therapeutic intervention against Chagas disease. To validate drug targets within the T(SH)2 metabolism, the strategies and methods of Metabolic Control Analysis and kinetic modeling of the metabolic pathway were used here, to identify the steps that mainly control the pathway fluxes and which could be appropriate sites for therapeutic intervention. For that purpose, gamma-glutamylcysteine synthetase (γECS), trypanothione synthetase (TryS), trypanothione reductase (TryR) and the tryparedoxin cytosolic isoform 1 (TXN1) were separately overexpressed to different levels in T. cruzi epimastigotes and their degrees of control on the pathway flux as well as their effect on drug resistance and infectivity determined. Both experimental in vivo as well as in silico analyses indicated that γECS and TryS control T(SH)2 synthesis by 60-74% and 15-31%, respectively. γECS overexpression prompted up to a 3.5-fold increase in T(SH)2 concentration, whereas TryS overexpression did not render an increase in T(SH)2 levels as a consequence of high T(SH)2 degradation. The peroxide reduction flux was controlled for 64-73% by TXN1, 17-20% by TXNPx and 11-16% by TryR. TXN1 and TryR overexpression increased H2O2 resistance, whereas TXN1 overexpression increased resistance to the benznidazole plus buthionine sulfoximine combination. γECS overexpression led to an increase in infectivity capacity whereas that of TXN increased trypomastigote bursting. The present data suggested that inhibition of high controlling enzymes such as γECS and TXN1 in the T(SH)2 antioxidant pathway may compromise the parasite's viability and infectivity. SN - 2213-2317 UR - https://www.unboundmedicine.com/medline/citation/31203195/Gamma_glutamylcysteine_synthetase_and_tryparedoxin_1_exert_high_control_on_the_antioxidant_system_in_Trypanosoma_cruzi_contributing_to_drug_resistance_and_infectivity_ L2 - https://linkinghub.elsevier.com/retrieve/pii/S2213-2317(18)31207-2 DB - PRIME DP - Unbound Medicine ER -